Market Access News | pharmaphorum

News

Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 K27M mutations.

News

More details have emerged of a UK plan for new medicines to get simultaneous decisions from the MHRA and NICE on their use by the NHS.

News

After a 17-year absence, a dydrogesterone-only hormone replacement therapy (HRT) formulation is available again in the UK market.

News

Medical groups critical of the direction of vaccine policy in the US are being excluded from the recommendation-setting process.

News

The UK has started a gonorrhoea vaccination programme designed to prevent thousands of infections and save the NHS millions of pounds.

News

Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug for rare disease familial chylomicronaemia syndrome.